pegbovigrastim

النصوص أدناه منقولة حرفياً وبلغتها الأصلية من نشرات الأدوية البيطرية المعتمدة لدى إدارة الغذاء والدواء الأمريكية (FDA) وقاعدة بيانات DailyMed.

دواعي الاستعمال (1)

Cattle (1)
  • Cattle (Periparturient Dairy Cows and Periparturient Replacement Heifers)

    For the reduction in the incidence of clinical mastitis in the first 30 days of lactation in periparturient dairy cows and periparturient replacement dairy heifers.

    For subcutaneous injection in periparturient dairy cows and periparturient replacement heifers. Do not use to treat cows with clinical mastitis becuase effectiveness has not been demonstrated for this use. Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

    Imrestor™

الجرعات (1)

Cattle (1)
  • Cattle (Periparturient Dairy Cows and Periparturient Replacement Heifers)

    Administer the first dose (syringe) 7 days prior to the cow’s or heifer’s anticipated calving date. If necessary, the first dose may be administered within a range of 4 to 10 days prior to the anticipated calving date to accommodate management schedules. Administer the second dose (syringe) within 24 hours after calving.

    Subcutaneous

    For subcutaneous injection in periparturient dairy cows and periparturient replacement heifers. Do not use to treat cows with clinical mastitis becuase effectiveness has not been demonstrated for this use. Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

    Imrestor™

التراكيز المتوفرة (1)

المنتجالشكل الصيدلانيالتراكيز المتوفرة
Imrestor™Injection15 mg pegbovigrastim per 2.7 mL syringe